by Mark Chiang

由马克·蒋

Share To

分享到

Pharmaceutical companies are increasingly adopting hybrid engagement strategies to connect with healthcare professionals (HCPs), according to recent research conducted by Elsevier and presented in a video released on August 7, 2023. The study highlights the industry’s evolving approach to communication, combining digital tools with traditional in-person interactions to meet the changing preferences of HCPs.

根据爱思唯尔进行的最新研究，并在2023年8月7日发布的视频中展示，制药公司越来越多地采用混合互动策略与医疗保健专业人员（HCP）建立联系。该研究强调了行业沟通方式的演变，结合数字工具与传统的面对面互动，以满足HCP不断变化的偏好。

This shift reflects broader trends in professional engagement across industries, emphasizing flexibility and accessibility..

这一转变反映了各行各业在专业参与方面的更广泛趋势，强调了灵活性和可及性。

The findings reveal that pharmaceutical firms are leveraging virtual platforms alongside face-to-face meetings to enhance their outreach efforts. These hybrid models aim to provide HCPs with more personalized and convenient ways to access information about medical advancements, treatments, and products.

研究结果显示，制药公司正在利用虚拟平台与面对面会议相结合的方式来加强其推广工作。这些混合模式旨在为医疗保健专业人士提供更加个性化和便捷的方式，以获取有关医学进展、治疗方案和产品的信息。

The report underscores the importance of tailoring communication methods based on individual preferences while maintaining compliance with regulatory standards. The video presentation explores how these strategies are being implemented and examines their impact on fostering stronger connections between pharma representatives and healthcare providers..

该报告强调了根据个人偏好调整沟通方法的重要性，同时保持符合监管标准。视频演示探讨了这些策略如何实施，并检查了它们对加强制药代表和医疗保健提供者之间更紧密联系的影响。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: August 7, 2023

日期：2023年8月7日

Related posts:

相关内容：

Breakthrough AI Tool Identifies Life-Saving Medication for Rare Disease Patient

突破性人工智能工具为罕见病患者识别出救命药物

Generic Drug Makers Navigate Patent Thickets and Stability Testing, Including Temperature, Humidity, and Light Factors, to Ensure Freedom to Operate

通用药物制造商在专利丛林和稳定性测试中穿行，包括温度、湿度和光照等因素，以确保操作自由。

Study Finds Slightly Increased Risk of Age-Related Macular Degeneration in Diabetic Patients Using GLP-1 Drugs

研究发现使用GLP-1药物的糖尿病患者年龄相关性黄斑变性的风险略有增加

Automated Synthesis and Computational Tools Streamline Early-Stage Drug Development

自动化合成与计算工具加速早期药物开发

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作：

[email protected]

[email protected]

Author

作者

Mark Chiang

蒋志光

Related Post

相关内容

News Flash

新闻快讯

Pfizer CEO Albert Bourla Discusses Balancing Innovation and Global Medicine Access in Reuters Interview

辉瑞首席执行官阿尔伯特·布尔拉在路透社采访中讨论了平衡创新与全球药物可及性的问题

2025-06-07

2025年6月7日